What starting dose and infusion rate of remifentanil should be used for a 100‑kg intubated, agitated, hypotensive adult when one 5‑mg (5000‑µg) vial is diluted in 100 mL normal saline?

Remifentanil Infusion for a 100-kg Hypotensive Agitated Patient

Critical Pre-Administration Requirements

Do not start remifentanil until hypotension is corrected with fluid resuscitation and vasopressor support, as remifentanil will worsen hypotension through direct vasodilation and bradycardia. 1, 2, 3

• Administer a minimum 30 mL/kg crystalloid bolus (3000 mL for this 100-kg patient) before or concurrent with any sedative agent 4
• Start norepinephrine infusion immediately to target mean arterial pressure ≥65 mmHg before initiating remifentanil 4, 5
• Place an arterial line for continuous blood pressure monitoring as soon as practical 4
• Central venous access is strongly preferred for norepinephrine to minimize extravasation risk 4, 5

Remifentanil Preparation from 5-mg Vial in 100 mL Saline

Your 5-mg vial diluted in 100 mL normal saline yields a concentration of 50 mcg/mL. 6

• This concentration is appropriate for adult use and matches FDA-approved dilution guidelines 6
• The solution is stable and ready for infusion pump administration 6

Starting Dose for This Hypotensive Patient

Start remifentanil at 0.025 mcg/kg/min (2.5 mcg/min or 3 mL/h) given the patient's hypotension, then titrate cautiously upward every 5 minutes based on agitation control and hemodynamic tolerance. 7, 6, 3

Dose Calculation for 100-kg Patient Using 50 mcg/mL Concentration:

• Initial rate: 0.025 mcg/kg/min = 2.5 mcg/min = 3 mL/h 6
• If inadequate sedation after 5 minutes: increase to 0.05 mcg/kg/min = 5 mcg/min = 6 mL/h 6
• Typical maintenance range: 0.05–0.1 mcg/kg/min = 5–10 mcg/min = 6–12 mL/h 7, 6
• Maximum for ICU sedation: 0.15 mcg/kg/min = 15 mcg/min = 18 mL/h 6

Rationale for Low Starting Dose:

• Remifentanil causes dose-dependent hypotension through direct arterial vasodilation, independent of respiratory depression 1
• In elderly or unstable patients, the FDA recommends reducing starting doses by 50% 6
• Remifentanil produces bradycardia through centrally mediated vagotonic effects that are additive to hypotension 2, 8
• The Association of Anaesthetists recommends using lower opioid doses in hemodynamically unstable patients to prevent cardiovascular collapse 7

Concurrent Vasopressor Management

Ensure norepinephrine is running at adequate rates before and during remifentanil titration to counteract predictable hypotension. 4, 5

• Start norepinephrine at 0.5 mg/h (8 mcg/min or 0.1 mcg/kg/min for this 100-kg patient) 4
• Titrate norepinephrine every 4 hours by 0.5 mg/h increments to maintain MAP ≥65 mmHg 4
• If norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, add vasopressin 0.03–0.04 units/min 4
• Monitor blood pressure every 5–15 minutes during initial remifentanil titration 4

Monitoring Protocol

• Continuous arterial blood pressure monitoring via arterial line 4
• Heart rate monitoring for bradycardia (remifentanil commonly reduces heart rate by 10–20 bpm) 2, 8
• Respiratory rate and end-tidal CO₂ (remifentanil causes dose-dependent respiratory depression) 1
• Assess sedation level and agitation control every 5 minutes during titration 7
• Tissue perfusion markers: lactate clearance, urine output >50 mL/h, capillary refill 4

Critical Pitfalls to Avoid

• Never start remifentanil without concurrent vasopressor support in a hypotensive patient—remifentanil directly dilates peripheral vasculature and will worsen shock 1, 2
• Do not use atropine prophylactically—atropine prevents bradycardia but does not prevent hypotension and may mask inadequate volume resuscitation 2, 8
• Avoid rapid bolus dosing—remifentanil should be administered as continuous infusion only, not as bolus in ICU sedation 6
• Do not mix remifentanil with alkaline solutions (e.g., sodium bicarbonate) in the same IV line, as this inactivates the drug 7
• Plan for transition analgesia—remifentanil's context-sensitive half-time is only 3.2 minutes, so pain will return rapidly upon discontinuation unless longer-acting opioids or regional analgesia are provided 9

Dose Adjustment Based on Response

• If agitation persists and MAP remains ≥65 mmHg: increase remifentanil by 0.025 mcg/kg/min every 5 minutes 6
• If hypotension develops (MAP <65 mmHg): hold remifentanil increase, escalate norepinephrine first, then resume remifentanil titration once MAP stabilized 4, 5
• If severe bradycardia occurs (HR <50 bpm): reduce remifentanil dose by 50% and consider atropine 0.5 mg IV 7, 2
• If respiratory depression occurs: reduce remifentanil dose immediately; effect will dissipate within 5–10 minutes due to rapid clearance 9

Special Considerations for This Patient

• Ideal body weight dosing: If this 100-kg patient is obese (>30% over ideal body weight), calculate doses based on ideal body weight instead of actual weight 6
• Age adjustment: If patient is >65 years old, start at 50% of the recommended dose (0.0125 mcg/kg/min) 6
• Renal/hepatic dysfunction: No dose adjustment needed—remifentanil is metabolized by plasma esterases, not liver or kidneys 9